Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats

One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor ant...

Full description

Saved in:
Bibliographic Details
Published in:Psychopharmacologia Vol. 116; no. 2; pp. 237 - 241
Main Authors: PONCELET, M, SOUILHAC, J, GUEUDET, C, TERRANOVA, J. P, GULLY, D, LE FUR, G, SOUBRIE, P
Format: Journal Article
Language:English
Published: Berlin Springer 01-10-1994
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist (0.04-0.64 mg/kg orally), antagonizes (50-65%) yawning induced by apomorphine (0.07 mg/kg SC) or bromocriptine (2 mg/kg IP) in rats, and turning behaviour induced by intrastriatal injection of apomorphine (0.25 micrograms), (+) SKF 38393 (0.1 micrograms), bromocriptine (0.01 ng) or (+) amphetamine (10 micrograms) in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation.
AbstractList One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonist have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist, antagonizes (50-65%) yawning induced by apomorphine or bromocriptine in rats, and turning behaviour induced by intrastriatal injection of apomorphine, (+) SKF 38393 bromocriptine or (+) amphetamine in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation. (DBO)
One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist (0.04-0.64 mg/kg orally), antagonizes (50-65%) yawning induced by apomorphine (0.07 mg/kg SC) or bromocriptine (2 mg/kg IP) in rats, and turning behaviour induced by intrastriatal injection of apomorphine (0.25 micrograms), (+) SKF 38393 (0.1 micrograms), bromocriptine (0.01 ng) or (+) amphetamine (10 micrograms) in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation.
Author SOUILHAC, J
PONCELET, M
LE FUR, G
GULLY, D
SOUBRIE, P
GUEUDET, C
TERRANOVA, J. P
Author_xml – sequence: 1
  givenname: M
  surname: PONCELET
  fullname: PONCELET, M
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 2
  givenname: J
  surname: SOUILHAC
  fullname: SOUILHAC, J
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 3
  givenname: C
  surname: GUEUDET
  fullname: GUEUDET, C
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 4
  givenname: J. P
  surname: TERRANOVA
  fullname: TERRANOVA, J. P
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 5
  givenname: D
  surname: GULLY
  fullname: GULLY, D
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 6
  givenname: G
  surname: LE FUR
  fullname: LE FUR, G
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
– sequence: 7
  givenname: P
  surname: SOUBRIE
  fullname: SOUBRIE, P
  organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3315483$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/7862953$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9rFjEQxoNU6tvqxbuQg3go3Zq_m-yxllYLBaHqeckmE43sJmuSbfFL-Jkb6Us9OpcZnvnNM4fnCB3EFAGh15ScUULU-w9XhDEhSa-eoR0VnHWMKHaAdoRw3nEq9Qt0VMpP0kpocYgOle7ZIPkO_bn0HmwtOHn85RYL3Q_sFBtcYG5yuAPcfnUrrDW4NsOWU4VYQsQZbFNTxiZW8z3FUOopThHX-4RdWs0SInQOVogOYsUT_DB3IW3ZzO20rCkWKLj5LMFC83A4m1peoufezAVe7fsx-nZ1-fXiU3fz-eP1xflNZ5lUtQPvjQQ99JNhEgxjlNlecaAaiBwEcdYqOYEn1BCnNZm0dBQm2feDVoNn_Bi9e_Rdc_q1QanjEoqFeTYR0lZGpVQvqZD_BWmviZKCN_DkEbQ5lZLBj2sOi8m_R0rGvymN_1Jq8Ju96zYt4J7QfSxt_3a_N8Wa2WcTbShPGG-RCs35A3FJm-Q
CODEN PSYPAG
CitedBy_id crossref_primary_10_1006_frne_1996_0146
crossref_primary_10_1016_j_reprotox_2023_108498
crossref_primary_10_1016_0143_4179_95_90053_5
crossref_primary_10_1016_j_peptides_2003_06_004
crossref_primary_10_1016_S0006_8993_96_01380_7
crossref_primary_10_1016_j_schres_2011_10_013
crossref_primary_10_1016_S0165_6147_97_90666_0
crossref_primary_10_1111_j_1749_6632_1997_tb46151_x
crossref_primary_10_1016_S0143_4179_96_90002_5
crossref_primary_10_1016_j_peptides_2006_04_024
crossref_primary_10_1111_j_1472_8206_1995_tb00528_x
crossref_primary_10_1016_j_bbr_2014_11_014
crossref_primary_10_1016_j_neuropharm_2004_03_001
crossref_primary_10_1016_S0165_6147_97_01109_7
crossref_primary_10_1046_j_1471_4159_2001_00353_x
crossref_primary_10_1002__SICI_1098_2396_199708_26_4_370__AID_SYN5_3_0_CO_2_3
Cites_doi 10.1073/pnas.89.12.5591
10.1016/0163-7258(89)90046-6
10.1016/0006-8993(89)90627-6
10.1007/BF00178206
10.1016/0028-3908(93)90057-A
10.1016/0196-9781(91)90129-D
10.1016/0028-3908(89)90194-9
10.1016/0091-3057(91)90307-N
10.1016/0014-2999(89)90098-8
10.1016/0304-3940(92)90698-7
10.1016/0028-3908(85)90190-X
10.1016/0304-3940(90)90721-K
10.1007/BF00310640
10.1016/0304-3940(94)90851-6
10.1016/0024-3205(86)90397-8
10.1111/j.1476-5381.1992.tb09037.x
10.1016/0006-8993(91)90139-M
10.1073/pnas.90.1.65
10.1016/0165-0173(93)90008-N
10.1016/0014-2999(90)90361-9
10.1016/0014-2999(78)90134-6
10.1016/0028-3908(91)90038-D
10.1016/0091-3057(84)90229-6
ContentType Journal Article
Copyright 1995 INIST-CNRS
Copyright_xml – notice: 1995 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QG
7TK
7X8
DOI 10.1007/BF02245067
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Animal Behavior Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Neurosciences Abstracts
Animal Behavior Abstracts
MEDLINE - Academic
DatabaseTitleList Neurosciences Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 241
ExternalDocumentID 10_1007_BF02245067
7862953
3315483
Genre Journal Article
GroupedDBID -4W
-BR
.55
3SX
40D
40E
95.
95~
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
IQODW
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QG
7TK
7X8
ID FETCH-LOGICAL-c257t-effa5e896ba25ea2212c673e18e05940dcc75bef01a0d880b85d1eb5669879f23
ISSN 0033-3158
IngestDate Fri Aug 16 07:34:02 EDT 2024
Fri Aug 16 08:46:06 EDT 2024
Fri Aug 23 02:16:33 EDT 2024
Sat Sep 28 08:38:20 EDT 2024
Tue Sep 20 22:55:05 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Vertebrata
Mammalia
Dopamine
Rat
Mouse
Dopamine receptor
Animal
Neuromediator
Rodentia
Behavior
Neurotensin
Catecholamine
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c257t-effa5e896ba25ea2212c673e18e05940dcc75bef01a0d880b85d1eb5669879f23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 7862953
PQID 16807543
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_77765145
proquest_miscellaneous_16807543
crossref_primary_10_1007_BF02245067
pubmed_primary_7862953
pascalfrancis_primary_3315483
PublicationCentury 1900
PublicationDate 1994-10-00
PublicationDateYYYYMMDD 1994-10-01
PublicationDate_xml – month: 10
  year: 1994
  text: 1994-10-00
PublicationDecade 1990
PublicationPlace Berlin
PublicationPlace_xml – name: Berlin
– name: Germany
PublicationTitle Psychopharmacologia
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 1994
Publisher Springer
Publisher_xml – name: Springer
References CT Dourish (BF02245067_CR3) 1985; 24
CB Nemeroff (BF02245067_CR12) 1983; 225
NRF Al-Rhodan (BF02245067_CR1) 1991; 557
KM Merchant (BF02245067_CR10) 1990; 255
B Sanz (BF02245067_CR18) 1993; 4
FB Jolicoeur (BF02245067_CR7) 1991; 38
KM Merchant (BF02245067_CR9) 1989; 160
AJ Puech (BF02245067_CR16) 1978; 50
MJ During (BF02245067_CR4) 1992; 140
P Worms (BF02245067_CR26) 1986; 39
V Seutin (BF02245067_CR19) 1989; 28
M Poncelet (BF02245067_CR14) 1993; 32
JL Waddington (BF02245067_CR25) 1989; 43
AJ Bean (BF02245067_CR2) 1990; 108
K Fuxe (BF02245067_CR5) 1992; 89
NA Singh (BF02245067_CR20) 1990; 187
S Tanganelli (BF02245067_CR23) 1989; 502
MR Zarrindast (BF02245067_CR27) 1992; 105
M Morelli (BF02245067_CR11) 1986; 89
I Ushijima (BF02245067_CR24) 1984; 21
D Gully (BF02245067_CR6) 1993; 90
D Nouel (BF02245067_CR13) 1991; 12
P W Kalivas (BF02245067_CR8) 1993; 18
R Steinberg (BF02245067_CR21) 1994; 166
M Poncelet (BF02245067_CR15) 1994; 349
R Rivest (BF02245067_CR17) 1991; 30
AJ Stoessel (BF02245067_CR22) 1987; 93
References_xml – volume: 89
  start-page: 5591
  year: 1992
  ident: BF02245067_CR5
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.89.12.5591
  contributor:
    fullname: K Fuxe
– volume: 43
  start-page: 1
  year: 1989
  ident: BF02245067_CR25
  publication-title: Pharmacol Ther
  doi: 10.1016/0163-7258(89)90046-6
  contributor:
    fullname: JL Waddington
– volume: 502
  start-page: 319
  year: 1989
  ident: BF02245067_CR23
  publication-title: Brain Res
  doi: 10.1016/0006-8993(89)90627-6
  contributor:
    fullname: S Tanganelli
– volume: 349
  start-page: 57
  year: 1994
  ident: BF02245067_CR15
  publication-title: Naunyn-Schmiedeberg's Arch Pharmacol
  doi: 10.1007/BF00178206
  contributor:
    fullname: M Poncelet
– volume: 4
  start-page: 1194
  year: 1993
  ident: BF02245067_CR18
  publication-title: NeuroReport
  contributor:
    fullname: B Sanz
– volume: 32
  start-page: 605
  year: 1993
  ident: BF02245067_CR14
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(93)90057-A
  contributor:
    fullname: M Poncelet
– volume: 12
  start-page: 755
  year: 1991
  ident: BF02245067_CR13
  publication-title: Peptides
  doi: 10.1016/0196-9781(91)90129-D
  contributor:
    fullname: D Nouel
– volume: 28
  start-page: 949
  year: 1989
  ident: BF02245067_CR19
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(89)90194-9
  contributor:
    fullname: V Seutin
– volume: 38
  start-page: 463
  year: 1991
  ident: BF02245067_CR7
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(91)90307-N
  contributor:
    fullname: FB Jolicoeur
– volume: 160
  start-page: 409
  year: 1989
  ident: BF02245067_CR9
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(89)90098-8
  contributor:
    fullname: KM Merchant
– volume: 140
  start-page: 129
  year: 1992
  ident: BF02245067_CR4
  publication-title: Neurosci Lett
  doi: 10.1016/0304-3940(92)90698-7
  contributor:
    fullname: MJ During
– volume: 24
  start-page: 1051
  year: 1985
  ident: BF02245067_CR3
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(85)90190-X
  contributor:
    fullname: CT Dourish
– volume: 108
  start-page: 143
  year: 1990
  ident: BF02245067_CR2
  publication-title: Neurosci Lett
  doi: 10.1016/0304-3940(90)90721-K
  contributor:
    fullname: AJ Bean
– volume: 93
  start-page: 336
  year: 1987
  ident: BF02245067_CR22
  publication-title: Psychopharmacology
  contributor:
    fullname: AJ Stoessel
– volume: 89
  start-page: 259
  year: 1986
  ident: BF02245067_CR11
  publication-title: Psychopharmacology
  doi: 10.1007/BF00310640
  contributor:
    fullname: M Morelli
– volume: 166
  start-page: 106
  year: 1994
  ident: BF02245067_CR21
  publication-title: Neurosci Letter
  doi: 10.1016/0304-3940(94)90851-6
  contributor:
    fullname: R Steinberg
– volume: 225
  start-page: 337
  year: 1983
  ident: BF02245067_CR12
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: CB Nemeroff
– volume: 39
  start-page: 2199
  year: 1986
  ident: BF02245067_CR26
  publication-title: Life Sci
  doi: 10.1016/0024-3205(86)90397-8
  contributor:
    fullname: P Worms
– volume: 105
  start-page: 675
  year: 1992
  ident: BF02245067_CR27
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1992.tb09037.x
  contributor:
    fullname: MR Zarrindast
– volume: 557
  start-page: 227
  year: 1991
  ident: BF02245067_CR1
  publication-title: Brain Res
  doi: 10.1016/0006-8993(91)90139-M
  contributor:
    fullname: NRF Al-Rhodan
– volume: 90
  start-page: 65
  year: 1993
  ident: BF02245067_CR6
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.90.1.65
  contributor:
    fullname: D Gully
– volume: 18
  start-page: 75
  year: 1993
  ident: BF02245067_CR8
  publication-title: Brain Res Rev
  doi: 10.1016/0165-0173(93)90008-N
  contributor:
    fullname: P W Kalivas
– volume: 255
  start-page: 775
  year: 1990
  ident: BF02245067_CR10
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: KM Merchant
– volume: 187
  start-page: 337
  year: 1990
  ident: BF02245067_CR20
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(90)90361-9
  contributor:
    fullname: NA Singh
– volume: 50
  start-page: 291
  year: 1978
  ident: BF02245067_CR16
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(78)90134-6
  contributor:
    fullname: AJ Puech
– volume: 30
  start-page: 25
  year: 1991
  ident: BF02245067_CR17
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(91)90038-D
  contributor:
    fullname: R Rivest
– volume: 21
  start-page: 297
  year: 1984
  ident: BF02245067_CR24
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(84)90229-6
  contributor:
    fullname: I Ushijima
SSID ssj0000484
ssj0068394
Score 1.5943074
Snippet One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 237
SubjectTerms 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - antagonists & inhibitors
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology
Animals
Apomorphine - antagonists & inhibitors
Apomorphine - pharmacology
Behavior, Animal - drug effects
Behavioral psychophysiology
Biological and medical sciences
Bromocriptine - antagonists & inhibitors
Bromocriptine - pharmacology
Dopamine - physiology
Dose-Response Relationship, Drug
Female
Fundamental and applied biological sciences. Psychology
Male
Mice
Motor Activity - drug effects
Neurotransmission and behavior
Penile Erection - drug effects
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Pyrazoles - pharmacology
Quinolines - pharmacology
Rats
Rats, Wistar
Receptors, Neurotensin - antagonists & inhibitors
Stereotyped Behavior - drug effects
Yawning - drug effects
Title Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats
URI https://www.ncbi.nlm.nih.gov/pubmed/7862953
https://search.proquest.com/docview/16807543
https://search.proquest.com/docview/77765145
Volume 116
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpC2MwxtatLNu6CTb6khhs-SL5sWzuwsi60LjQNyNLMht0cUjilv2J_eYdWbKVUHZ72ItxhCMnnM_nYn3nE0JvBYS5JC0FFDll6kG8Vh6HwO0RUVEWiJCHrbr-ZE7Pr9j7LMoGg44s7Mb-q6VhDGytO2f_wdr9pDAA52BzOILV4fhXds8cQWN-MYpYkpKWoTlatzveaKIQVPzeUrNZJJxrcY6Wxa77WjTHpWVV6rUqramrv6qXE27rkYTy-hvkpF63b-6m6_FvlTtWhmzb8rtGeo97w1znRimqy3-Nv106vez-jf5M909em6URt8dx3Xy9_sLFzvrVh0Y10lzoXpKrFQTd-sYwf23TmrTdfVFPi-sddKjb_Yyae--gTTemRSLZdrdGMMZGbmIktO4EBb-jukO6EvsJdaGvW-4__1ycXU6nRZ5d5XvogIDTAp95cJp9nExdXI90S6_5kEBeaQS-7e_dVb61N9rJdR4s-Roeu8rsl_LrgqZNbPJH6KGtSPCpgdJjNFCLQ3Tvk-VcHKKTmbHW9zHOXbPeeoxP8GzLjk_QDws9XFd4foFb6I0xxz3w8Bbw8BbwcAc87IA3xvUCA-zwXdjhLdjhHnYY5tGwgzkk1rB7ii7PsvzdxLPbfXgC4sbGU1XFY8XSpOQkVpxAUiUSGqqAKS0q5EshaFyqyg-4LyHslCyWgSqhHkkZTSsSHqF9-B_qmRYioDIIREB4UEZExjwKmEgheCWM8YrKIXrTGaZYGlWXotPvduYbouMdm_WXhqEu9MMhet3ZsACnrFfa-ELVzboIEq3xHf3mCkppArVKPERHxvj95JQlJI3D53-c_AW67x6hl2h_s2rUMdpby-aVhe5PlqC_3A
link.rule.ids 315,782,786,27933,27934
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+SR+48692%2C+a+selective+non-peptide+neurotensin+receptor+antagonist%2C+on+two+dopamine-dependent+behavioural+responses+in+mice+and+rats&rft.jtitle=Psychopharmacology&rft.au=Poncelet%2C+M&rft.au=Souilhac%2C+J&rft.au=Gueudet%2C+C&rft.au=Terranova%2C+J+P&rft.date=1994-10-01&rft.issn=0033-3158&rft.volume=116&rft.issue=2&rft.spage=237&rft.epage=241&rft_id=info:doi/10.1007%2FBF02245067&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon